The Top Line artwork

Business News · Fierce Life Sciences

The Top Line

by Fierce Life Sciences

Biopharma and medtech explained. Every week, journalists from Fierce Biotech, Fierce Medtech, and Fierce Pharma recount the latest industry trends and why they matter. We'll analyze the week's biggest business news, from mergers and marketing to drug R&D and device development. Available every Friday morning. 

Latest episodes

Showing 20 · updated from the feed

Digital Twins: Advancing Clinical Evidence Strategy (Sponsored)

Patient digital twins give life sciences teams a framework for evaluating how an individual patient’s health trajectory could change under different treatments or scenari

Nov 16
20 min

The promise of molecular gates and what comes next

Gate Bioscience is betting that a decades-old biological mechanism could pave the way for a new class of medicines. The biotech is developing small molecules that selecti

Nov 13
14 min

Building a More Resilient Biomanufacturing Supply Network (Sponsored)

Biomanufacturing supply networks must deliver consistency while remaining flexible enough to respond to changing demand, material availability and regional requirements.

Nov 11
6 min

How Smarter Healthcare Environments Improve Patient Experience (Sponsored)

Patient experience is shaped by more than clinical care. It begins with transportation, parking and wayfinding, and continues through check-in, the patient room, diagnost

Nov 11
25 min

Use Kidney Genetics to Strengthen Clinical Trial Design (Sponsored)

Broad chronic kidney disease labels can obscure distinct biology, complicating patient selection, progression assumptions and treatment-signal interpretation. In this spo

Nov 9
15 min

When China Fits a Global Clinical Development Strategy (Sponsored)

China can play several roles in a global clinical development program, from supporting a capital-efficient proof-of-concept study to contributing evidence within a multir

Nov 6
17 min

There's more than one way to build a biotech

As biotech companies continue to navigate a challenging funding environment, Axiom Biosciences is taking an unconventional approach to raising capital and developing new

Nov 6
16 min

When drug development gets personal

For nearly three decades, Jigar Raythatha has helped build biotech companies and bring new medicines to patients. But in 2023, the Third Rock Ventures partner found himse

Oct 30
28 min

How AI turns field conversations into actionable insights (Sponsored)

Life science field teams are a major source of customer insight, but growing complexity, limited HCP access and expanding omnichannel demands can make it difficult to tur

Oct 28
16 min

GSK's double FDA win, Roche's $15B deal and the rise of point-of-care marketing

In this week's episode of "The Top Line," we're covering a pair of FDA approvals for GSK, an antibody-drug conjugate pact worth up to $15 billion and the growing role of

Oct 23
15 min

Inside Teva's Weltruza launch and Novo's GLP-1 strategy

In this week's episode of "The Top Line," we're looking at two companies building on recent successes and pursuing new opportunities in the pharmaceutical industry. From

Oct 16
25 min

The Next Chapter for AI in Clinical Trials [Sponsored]

Clinical AI is moving from systems that predict and summarize toward agents that can help execute parts of a workflow. In this sponsored episode of The Top Line, Will Hur

Oct 15
32 min

How AI could improve clinical trial decision-making (Sponsored)

What if clinical development teams could evaluate potential trial outcomes before a study reaches patients? In this sponsored episode of The Top Line, host Irena Luo spea

Oct 12
22 min

How we picked the Fierce 15

What does it mean to be a Fierce 15 biotech in 2026? With this year’s list unveiled, the Fierce Biotech team gets together to discuss what the winners tell us about the s

Oct 9
23 min

Locking in on pharma’s consumerization trend

With GLP-1s paving the way, a consumer shift is happening across markets for certain branded pharmaceuticals. Now, the CEO of a buzzy pattern-hair-loss biotech is eyeing

Oct 2
18 min

Fierce Pharma Week: A look at the biggest trends, campaigns and conversations

Fierce Pharma Week brought thousands of people to Philadelphia for four days of conversations about pharma marketing, commercialization, medical affairs and communication

Sep 25
24 min

Inside the growing world of biopharma prediction markets

Prediction markets are opening up new ways to bet on biopharma events, from clinical trial readouts to FDA approvals. But they also create a new set of risks for an indus

Sep 18
23 min

Clinical trials reach a new automation inflection point (Sponsored)

Clinical development organizations are facing mounting pressure to do more with increasingly complex protocols, larger data sets and tighter timelines. While automation h

Sep 14
17 min

The future of RAS inhibitors

Revolution Medicines recently made history with the approval of its RAS inhibitor Rasonque for advanced pancreatic cancer. But behind RevMed is an entire field of biotech

Sep 11
29 min

The people who stayed with the problem

The 2026 Fierce 50 includes people and organizations working on very different problems across biopharma and healthcare, from designing new proteins and developing cancer

Sep 4
25 min

Chart trend

Position in the Business News chart (US), last 90 days.

#16
all-time peak
473
days in the top 50 since Nov 2024

Chart positions

Where The Top Line ranks today in each Apple Podcasts chart (US, Nov 16, 2026).

#63 ▲ 2 Business News US

More podcasts like The Top Line

Popular shows in Business News, for your next listen.

Browse charts by category

Daily updated Apple Podcasts rankings for the United States.

About The Top Line on Reason.fm

Here you find the Apple Podcasts chart positions of The Top Line, its latest episodes to listen to directly, and reviews from listeners. Rankings are updated daily for the United States.

Contact

Questions or issues? Reach us at hello@reason.fm

0:000:00